throbber
letter
`
`© 2001 Nature Publishing Group http://genetics.nature.com
`
`Disruption of a new forkhead/winged-helix protein,
`scurfin, results in the fatal lymphoproliferative disorder
`of the scurfy mouse
`
`Mary E. Brunkow1, Eric W. Jeffery1, Kathryn A. Hjerrild1, Bryan Paeper1, Lisa B. Clark1, Sue-Ann Yasayko1,
`J. Erby Wilkinson2, David Galas3, Steven F. Ziegler4 & Fred Ramsdell1
`
`Scurfy (sf) is an X-linked recessive mouse mutant resulting in
`lethality in hemizygous males 16–25 days after birth, and is char-
`acterized by overproliferation of CD4+CD8– T lymphocytes,
`extensive multiorgan infiltration and elevation of numerous
`cytokines1–4. Similar to animals that lack expression of either
`Ctla-4 (refs. 5,6) or Tgf-β (refs. 7,8), the pathology observed in sf
`mice seems to result from an inability to properly regulate
`CD4+CD8– T-cell activity3,9. Here we identify the gene defective
`in sf mice by combining high-resolution genetic and physical
`mapping with large-scale sequence analysis. The protein
`encoded by this gene (designated Foxp3) is a new member of
`the forkhead/winged-helix family of transcriptional regulators
`and is highly conserved in humans. In sf mice, a frameshift muta-
`tion results in a product lacking the forkhead domain. Genetic
`complementation demonstrates that the protein product of
`Foxp3, scurfin, is essential for normal immune homeostasis.
`
`The sf locus was mapped originally to a 1.7-cM interval
`between DXWas70 and Otc in the proximal region of the mouse
`X chromosome1,10. We used an intersubspecific backcross to fur-
`ther localize sf to a 0.3-cM interval (Fig. A, see http://genetics.
`nature.com/supplementary_info/) and, in parallel, constructed a
`sequence-ready BAC contig across the entire DXMit123–Otc
`interval. Probe content mapping of 11 overlapping BACs span-
`ning the DXCch1–DXCch2 region, however, indicated that the 4
`clones K50, K90, K60 and K70 defined the minimum tiling path
`(Fig. 1a); this region was estimated to be approximately 500 kb.
`By random shotgun sequencing, we identified 20 putative genes
`on the 4 BACs (Fig. 1a), which corresponded well with a recently
`published map in which transcripts were identified primarily
`through direct cDNA selection11. We discovered through computa-
`tional analysis an ORF with strong homology to the DNA-binding
`domain of the forkhead/HNF3/winged-helix family of proteins.
`
`a
`
`DXCch1
`
`DXMit55
`
`~ 500 kb
`
`scurfy
`(Foxp3)
`
`Cacna1f
`Syp Lmo6 Plp2
`DXMit26
`AA124124
`왘
`
`©2001 Nature Publishing Group http://genetics.nature.com
`
`AA273854
`
`AF229644
`왘
`
`왗
`
`K50 (196K10)
`100
`
`K90 (349I6)
`150
`
`왗
`
`←
`
`Cen
`
`b
`
`Hp
`
`Bs
`
`-12.5 kb
`
`왘
`
`왘
`
`왗
`K60 (8C22)
`180
`
`AA030924
`AF229636
`AF229635
`AF229645
`Ppia-ps
`왘 왘 왘 왘
`왗
`
`mT54
`
`왗
`
`Tcfe3
`DXCch4
`
`Kcnd1
`
`Smt3h2-ps
`왘
`
`왘
`
`AW342118
`왘
`
`왘
`
`Pim2
`(DXCch3)
`DXCch2
`AF229642
`→
`왘왘
`Tel
`
`K70 (284K10)
`200
`
`-2b
`
`-2a
`
`-1
`
`1
`
`2 3
`
`4 5
`
`6 7
`
`8
`
`9
`
`Bs
`
`10 11
`
`Bs
`
`Hp
`
`+18.3 kb
`
`wild type
`....GGACAAGAGCTC..
`....GGACAAAAGAGCTC... scurfy
`
`Fig. 1 Physical map of the sf region, genomic organization of Foxp3 and the sf mutation. a, The 500-kb sf candidate interval is limited by markers DXCch1 and
`DXCch2. BAC clones K50, K60, K70, K90 and library ID (in parentheses) are indicated. Computational analysis of this region identified 20 putative genes, including
`nine known genes (in bold): Tcfe3, Kcnd1, Pim2 and “human CMV-interacting protein”, as well as the mouse orthologs for SYP, LMO6, PLP2, T54 (ref. 15) and
`CACNA1F (encoding the calcium channel α1 subunit disrupted in congenital stationary night blindness30,31; MIM 310500); and two pseudogenes (on lowest level)
`related to mouse Smt-3B and Ppia. For the remaining new genes (underlined), corresponding to ESTs and/or GENSCAN predictions, RT–PCR experiments further
`extended and confirmed transcript structure. The transcriptional orientation of each transcript is indicated by a filled arrowhead. Polymorphic markers are
`shown in italics. b, Genomic organization of Foxp3 and the sf mutation. Coding exons are shown as filled black boxes, whereas noncoding regions are open
`boxes. Lines connecting exons indicate splicing events and the observed alternate polyadenylation signal is indicated by the dashed line. Note the two different
`5´ noncoding exons (-2a and -2b), separated by 640 bp on the chromosome, both of which splice to a second, common noncoding exon (-1). The putative 5´ end
`of the most distal non-coding exon, ‘-2b’, located 6.1 kb upstream from the first coding exon corresponds well to a promoter region predicted by GENSCAN. The
`sf mutation is the result of a 2-bp insertion in exon 8 (indicated below the schematic). Exon 8 was amplified and sequenced directly from genomic DNAs derived
`from the sf mutant, as well as four inbred (C57BL/6J, 101/Rl, C3Hf/Rl, 129/SvJ) and three wild-derived inbred (CAST/Ei, MOLF/Ei, SPRET/Ei) strains of mice. As
`expected, the 2-bp insertion was specific for sf mice. The HpaI sites (Hp) used to generate the 30.8-kb Foxp3 transgene, as well as the BstXI sites (Bs) used for
`Southern-blot analysis are shown. The transgene includes the entire gene as well as 12.5 kb and 2.8 kb of 5´ and 3´ flanking sequence, respectively.
`
`1Celltech Chiroscience, Inc., Bothell, Washington, USA. 2Oak Ridge National Laboratory, Oak Ridge, Tennessee, USA. 3Keck Graduate Institute for
`Applied Life Sciences, Claremont, California, USA. 4Virginia Mason Research Center, Seattle, Washington, USA. Correspondence should be addressed to
`M.E.B. (e-mail: marybrunkow@chiroscience.com).
`
`68
`
`nature genetics • volume 27 • january 2001
`
`Page 1 of 6
`
`YEDA EXHIBIT NO. 2071
`MYLAN PHARM. v YEDA
`IPR2015-00644
`
`

`
`© 2001 Nature Publishing Group http://genetics.nature.com
`
`letter
`
`NLC sf /Y sf /Y; Tg
`
`NLC
`L S T
`
`1292L 1292H
`L S T L S T
`
`2826
`2827
`2828
`L S T L S T L S T
`
`b
`
`c
`
`Bs
`
`9
`
`10 11
`
`Bs
`
`Bs
`
`Hp
`[
`30.8 kb
`
`3.1 kb
`
`4.8 kb
`
`2827
`
`NLC
`
`2828
`
`NLC
`
`2826
`
`1292H
`
`1292L
`
`NLC
`
`a
`
`Hp
`
`Bs
`
`[
`0 kb
`
`endogenous only
`transgene only
`endogenous
`3.1
`+ transgene
`
`Fig. 2 Analysis of Foxp3 transgenic mice. a, Southern-blot analysis was performed
`on genomic DNA prepared from tail tips, digested with BstXI (Bs) and probed with
`the fragment indicated by a heavy horizontal bar in the schematic diagram. At the
`endogenous Foxp3 locus, this fragment hybridizes to 3.1- and 4.8-kb fragments
`(shown in schematic, and on Southern blot); in the case of multiple copies of the
`30.8-kb HpaI (Hp) transgene integrated in a head-to-tail array, the probe
`hybridizes to the same internal 3.1-kb fragment as well as an unique 3.6-kb frag-
`ment (indicated on Southern blot). Representative samples from normal littermate controls (NLC) and transgene (Tg) lines 1292L, 1292H, 2826, 2827 and 2828 are
`shown. Using the endogenous 4.8-kb BstXI fragment as an internal control in each lane, transgene copy numbers were determined by analysis with a PhosphorImager
`445 SI. The copy numbers indicated in Table 1 are the result of analyzing multiple animals from each transgenic line. Additional higher molecular weight bands most
`apparent in the analyses of lines 1292H, 2827 and 2828 represent the unique single-copy BstXI fragments generated at the sites of transgene insertion. b, Lymph nodes
`from NLC, sf/Y mutant, and sf/Y; Tg animals were removed at 12 days of age. Lymphoid organs appeared normal in all sf/Y; Tg animals examined, irrespective of trans-
`gene copy number. c, Foxp3 transgene expression level in spleen (S) and thymus (T) roughly correlates with copy number, as determined by northern-blot analysis of
`total RNA prepared from animals at 10 days of age. A major transcript is seen at ∼2.4 kb and a minor species, at ∼3.7 kb, the difference in length being due to the use
`of alternative polyadenylation sites. As with endogenous Foxp3, Tg expression is undetectable in liver (L). We loaded 20 µg total RNA in each lane.
`
`~3.7 kb
`~2.4 kb
`
`This new transcript was not represented in the EST database, nor
`was it identified in the study mentioned above.
`We evaluated candidates by direct sequencing of RT–PCR
`products obtained from mutant and normal animals. We
`observed a change in a protein-coding sequence in only the
`sequence of the new forkhead gene. The sequence derived from sf
`thymus RNA included a 2-bp insertion within the coding region
`(Fig. 1b), which was confirmed by direct sequencing of a PCR
`product obtained from sf genomic DNA. Likewise, the lack of this
`insertion in PCR products from genomic DNA of seven different
`mouse strains, as well as in the analogous cDNA from human,
`indicated that it was in fact unique to the sf mutant. The
`frameshift resulting from the insertion leads to a truncated gene
`product lacking the carboxy-terminal forkhead domain.
`We confirmed the identity of the sf gene by functional comple-
`mentation of the mutation in transgenic mice. A 30.8-kb
`genomic fragment containing the entire gene was used for
`microinjection of mouse ooctyes (Fig. 1b). We obtained 5 inde-
`pendent transgenic lines, with copy numbers ranging from 3 to
`approximately 70 (Fig. 2a). Transgenic (Tg) males were mated
`with sf Otcspf/++ carrier females, and the scurfy phenotype was
`analyzed in male progeny. As expected, 50% of the males carried
`the Otcspf (sparse-fur) allele; half of these animals also suc-
`cumbed to scurfy disease by 16–18 days of age. However,
`approximately 50% of the Otcspf males (also presumed to carry
`the sf mutation) survived to weaning; several of these animals
`were killed at approximately 4 weeks of age, and visual inspec-
`tion revealed normal lymph nodes (Fig. 2b), spleen and liver.
`Southern-blot analysis of these animals indicated that they car-
`ried the transgene. None of the Otcspf (and sf) males with scurfy
`disease were transgenic. We found complete rescue of the scurfy
`defect with all five transgenic lines (Table 1). Northern-blot
`
`analysis revealed elevated expression of the sf gene in spleen and
`thymus that roughly correlated with transgene copy number
`(Fig. 2c and Table 1). sf Otcspf/Y; Tg males show no other overt
`phenotype besides sparse-fur, and animals that are older than
`one year of age are fertile. Likewise, females carrying the trans-
`gene, with or without the sf mutation, also seem to be normal.
`The lymph nodes from transgenic animals, however, were often
`smaller than those of their littermate controls, primarily due to a
`decrease in total T-cell number (Fig. 3). This was particularly
`acute in animals with higher expression of the transgene, but the
`effect was less pronounced in the spleen. In contrast, the thymus
`of transgenic animals seemed to be normal in number of cells
`and phenotype. More detailed analyses of these transgenic mice
`will be presented elsewhere (manuscript in preparation).
`To rule out the possibility that the sf mutation results in a dom-
`inant-negative protein, we generated transgenic animals that
`overexpressed the sf form of the gene. In analysis of five indepen-
`dent lines, overexpression of the mutant gene did not result in
`any overt phenotype, nor did it rescue disease in scurfy mice
`(data not shown).
`We generated sequence of full-length sf cDNA by assembling
`overlapping RT–PCR, as well as 5´- and 3´-RACE products from a
`number of different tissues (embryo, thymus, spleen). Compari-
`son of cDNA with the BAC K60 sequence resulted in a gene struc-
`ture (Fig. 1b). Multiple forms of mature message are produced as
`a result of alternative noncoding first exons as well as polyadeny-
`lation sites. In keeping with the recent proposal to devise a stan-
`dard nomenclature for the rapidly growing family of forkhead
`genes12, the gene mutated in sf mice has been designated Foxp3,
`and we refer to the normal gene product as scurfin.
`We surveyed a large number of mouse tissues for expression of
`Foxp3 using real-time RT–PCR, and the gene Dad1 as an
`
`nature genetics • volume 27 • january 2001
`
`69
`
`©2001 Nature Publishing Group http://genetics.nature.com
`
`Page 2 of 6
`
`YEDA EXHIBIT NO. 2071
`MYLAN PHARM. v YEDA
`IPR2015-00644
`
`

`
`© 2001 Nature Publishing Group http://genetics.nature.com
`
`(see also http://www.biology.pomona.edu/fox.html). A sequence
`alignment including a selection of members from these various
`subfamilies, along with mouse and human FOXP3, is available
`(Fig. B, see http://genetics.nature.com/supplementary_info/). As
`in other family members, the scurfin winged-helix domain con-
`tains several basic residues at either end, which may serve to
`direct the protein to the nucleus19,20 (Fig. 5).
`Analysis of the scurfin sequence using BLAST and Motifs
`(GCG Wisconsin Package) also revealed the presence of a single
`C2H2 zinc-finger domain 116 amino acids upstream from the
`winged-helix domain. Aside from these two well-described func-
`tional motifs, the scurfin sequence is unique. In particular, we did
`not find a region with obvious similarity to previously described
`transcriptional activation domains. The identification of such a
`domain awaits further functional characterization of the protein.
`Foxp3 encodes a new member of the forkhead family of tran-
`scriptional regulators and is required for normal T-cell function.
`The Foxp3sf allele results in truncation of the protein and an appar-
`ent lack of functional activity. A number of other transcription fac-
`tors are critical for various aspects of lymphocyte development or
`lineage commitment21. Previous studies have demonstrated a
`causal association between expression of specific factors and com-
`mitment to a specific T-cell lineage, such as Th1 versus Th2 (for
`example, c-Maf (ref. 22), GATA-3 (ref. 23) and T-bet (ref. 24)), or
`maintenance of a quiescent state in T cells (for example, LKLF; ref.
`25). Our data suggest that the scurfin putative transcription factor
`is critical for control of immune responses and potentially T-cell
`number, acting as an apparent rheostat for T-cell activation, and
`functions predominantly in peripheral T cells.
`Both the cellular and biochemical mechanisms by which scurfin
`controls T-cell responses are yet to be determined. Although similar
`in phenotype to Ctla-4 and Tgf-β deficient mice, sf animals express
`
`NLC
`
`1292H 1292L
`
`2826
`
`2827
`
`2828
`
`scurfy
`
`NLC
`
`1292H 1292L
`
`2826
`
`2827
`
`2828
`
`scurfy
`
`NLC
`
`1292H 1292L
`
`2826
`
`2827
`
`2828
`
`scurfy
`
`6.0
`
`5.0
`
`4.0
`
`3.0
`
`2.0
`
`1.0
`
`0.0
`
`7.0
`
`6.0
`
`5.0
`
`4.0
`
`3.0
`
`2.0
`
`1.0
`
`0.0
`
`cell number (x106)
`
`ratio
`
`1.80
`1.60
`1.40
`1.20
`1.00
`0.80
`0.60
`0.40
`0.20
`0.00
`
`cells number (x106)
`
`
`
`a
`
`b
`
`c
`
`letter
`
`Table 1 • Scurfin transgene rescues scurfy disease
`
`Tg line
`
`1292L
`1292H
`2826
`2827
`2828
`
`Tg copy
`no.
`
`3
`9
`∼16
`∼70
`∼45
`Totals
`
`Genotype of males (no. with scurfy disease)
`wt
`wt
`sf
`non-Tg
`non-Tg
`Tg
`
`sf
`Tg
`
`1 (0)
`1 (0)
`0
`0
`1 (0)
`3 (0)
`
`2 (2)
`1 (1)
`1 (1)
`2 (2)
`0
`6 (6)
`
`2 (0)
`6 (0)
`4 (0)
`0
`8 (0)
`20 (0)
`
`2 (0)
`4 (0)
`1 (0)
`3 (0)
`4 (0)
`14 (0)
`
`For each of the five transgenic lines, the transgene was crossed onto the sf
`mutant background; resulting male progeny were genotyped with respect to
`sf mutation (wt or sf) and transgene (non-Tg or Tg) status. The number of ani-
`mals with scurfy disease within each genotypic class was ascertained (in paren-
`theses). The last column demonstrates that the presence of the transgene,
`from any of the five lines, prevents disease in genotypically sf animals. Tg,
`transgene; wt, wild type.
`
`endogenous reference13 (Fig. 4). We found the highest levels of
`Foxp3 expression in lymphoid organs such as thymus and
`spleen, consistent with transgene expression (Fig. 2c). Further
`analysis of subpopulations of purified lymphoid cells showed
`Foxp3 expression in Th1 and Th2 cells, and much lower (90%
`decreased) levels in CD4–CD8+ and B220+ cells.
`During the course of analyzing Foxp3, a highly conserved
`human sequence (JM2) was deposited in GenBank. The high
`degree of similarity with Foxp3, combined with the fact that JM2
`falls within a chromosomal region with the same gene organiza-
`tion as Foxp3 (refs. 11,14,15), indicates that JM2 represents the
`human ortholog. Because JM2 was generated through concep-
`tual translation of genomic sequence from Xp11.23, we isolated
`human FOXP3 cDNAs by RT–PCR from a variety of tissues and
`determined the complete coding sequence. There were a number
`of differences between our human FOXP3 sequence and JM2
`(Fig. 5). We have identified a single, noncoding exon located 6.1
`kb upstream from the first coding exon. The longest human
`FOXP3 transcript we have characterized so far includes a 5´ UTR
`of 188 bp, an ORF of 1,293 bp, and a 3´ UTR of 388 bp. Exon-
`intron boundaries are identical across the coding regions of the
`mouse and human genes. The complete mouse and human
`scurfin sequences are shown (Fig. 5).
`We compared the amino acid sequences of mouse and human
`scurfin with other members of the forkhead/winged-helix/HNF3
`family of proteins. Of all these family members, the strongest
`similarity was to the partial protein sequence called glutamine-
`rich factor16, recently designated Foxp1. Based on these align-
`ments, we localized the winged-helix domain of scurfin to the
`region between amino acid residues 337 and 420, at the C termi-
`nus of the protein (Fig. 5). The scurfin forkhead domain contains
`many of the sequence features thought to be important for medi-
`ating protein-DNA contacts based on co-crystallization data
`using HNF3-γ (ref. 17) and another predicted structure16 (see
`also the accompanying report by Wildin et al.18). Recent phyloge-
`netic analysis of all available forkhead domains from chordates
`has resulted in the assignment of each into 1 of 17 subfamilies12
`
`Fig. 3 Diminished T-cell numbers in lymph nodes from transgenic mice. Lymph
`node cells from representative normal littermate controls (NLC), sf mice and
`the various transgene lines were examined for cell number and phenotype.
`Total cell number (a) from lymph nodes of transgenic mice are consistently less
`than that in NLC animals, and the extent of reduction is roughly parallel to
`transgene expression. The ratio of CD4+8– to CD4–8+ cells in the lymph nodes
`is altered in high-copy transgenic mice, due in part to a decrease in the per-
`centage of CD4–8+ cells (b). The total number of CD4+8– T cells in the lymph
`nodes of transgenic mice is less than that of NLC as well as sf animals (c). The
`alterations in cell numbers are consistent in at least 5 mice per transgenic line
`analyzed between 4 and 16 weeks of age, and the phenotype remains consis-
`tent on backcrossing to C57Bl/6 mice for at least six generations.
`
`70
`
`nature genetics • volume 27 • january 2001
`
`©2001 Nature Publishing Group http://genetics.nature.com
`
`Page 3 of 6
`
`YEDA EXHIBIT NO. 2071
`MYLAN PHARM. v YEDA
`IPR2015-00644
`
`

`
`© 2001 Nature Publishing Group http://genetics.nature.com
`
`letter
`
`Fig. 4 Tissue distribution of Foxp3 expression. Levels of
`Foxp3 expression were determined using the standard
`curve method (separate tube reactions), in which Dad1
`served as endogenous reference, and the standard curve
`was generated from a dilution series of a standard cDNA
`sample. The standard curve was derived by plotting the
`threshold cycle (CT) versus starting quantity, in this case
`expressed in arbitrary units, and raw values for each of the
`two genes were then calculated from the CT of each test
`sample. The mean values from duplicate reactions for
`Dad1 (a) and Foxp3 (b) are shown. Normalized Foxp3 val-
`ues were then derived from the ratio of raw mean Foxp3
`to raw mean Dad1 value for each tissue sample (c). Mouse
`tissues analyzed were 18 days post coitum liver and thymus
`(lanes 1, 2); brain, heart, kidney, liver, lung, spleen and thy-
`mus from day 10 animals (lanes 3–9); brain, heart, kidney,
`lung, spleen and thymus adult tissues (lanes 10–15);
`CD4+CD8–, CD4–CD8+, B220+, Th1 and Th2 purified lym-
`phocytes (lanes 16–20); and no template control (lane 21).
`
`1
`
`2
`
`3
`
`4
`
`5
`
`6
`
`7
`
`8
`
`9
`
`10 11 12 13 14 15 16 17 18 19 20 21
`
`tissue
`
`1
`
`2
`
`3
`
`4
`
`5
`
`6
`
`7
`
`8
`
`9
`
`10 11 12 13 14 15 16 17 18 19 20 21
`
`tissue
`
`cDNA cloning and mutation detection. We extracted
`total RNA from thymus, spleen, brain and liver of 10-d
`normal and sf mice. We used total RNA (5 µg) to generate
`random-primed first-strand cDNA (SuperScript Pream-
`plification System, Gibco-BRL). For typical RT–PCR
`reactions, 1 µl cDNA (1/30th of total cDNA preparation)
`was used as template in a 25 µl reaction; typical amplifica-
`tion conditions on MJ Tetrad were 94 °C for 3 min, fol-
`lowed by 35 cycles of 94 °C for 60 s, 55 °C for 30 s, 72 °C
`for 60 s. The primers used for these experiments derived
`from all 18 transcription units located within the sf critical
`interval. In the case of known genes, we used published
`sequences to design primers spanning the entire cDNA.
`For new genes, primers were designed initially to span
`exons predicted by GENSCAN on partial genomic
`sequence contigs. RT–PCR products were either
`sequenced directly (using the same primers as were used
`for the initial amplification, as well as more internal
`primers as necessary) or cloned into the TA vector (Invit-
`rogen) and sequenced from vector-specific primers. The
`sf mutation was found by sequencing an ∼980-bp frag-
`ment resulting from amplification of spleen cDNA with
`the primers 5´–CTACCCACTGCTGGCAAATG–3´ and
`5´–GGTTGTGAGGGCTCTTTGAC–3´.
`For analysis of the sf mutation in genomic DNA,
`amplicons generated with primers 5´–CAGAGCCTG
`GTCTATACACTG–3´ and 5´–GAAGGAACTATTGC
`CATGGCTTC–3´ were sequenced directly using the same primers as in
`PCR. Cycling conditions were 94 °C for 5 min, followed by 35 cycles of 94
`°C for 45 s, 62 °C for 90 s, 72 °C for 90 s.
`
`Th1
`
`no te m pl.
`Th2
`
`6000
`
`5000
`
`4000
`
`3000
`
`2000
`
`1000
`
`0
`
`relative Dad1 mRNA
`
`a
`
`3000
`
`2500
`
`2000
`
`1500
`
`1000
`
`500
`
`0
`
`relativeFoxp3 mRNA
`
`b
`
`2
`1.8
`1.6
`1.4
`1.2
`1
`0.8
`0.6
`0.4
`0.2
`0
`
`(relative Foxp 3 / relative Dad1)
`
`c
`
`normalized mRNA levels
`
`©2001 Nature Publishing Group http://genetics.nature.com
`
`18 dpc thym us
`10 d brain
`C D4+C D8-
`10 d spleen
`ad brain
`10 d thym us
`ad thym us
`ad spleen
`10 d liver10 d lung
`
`18 dpc liver
`B220+
`10 d kidney
`C D4-C D8+
`ad lung
`10 d heart
`ad kidney
`ad heart
`
`both of these proteins. It remains to be determined which genes are
`regulated by scurfin activity, as does the mechanism by which
`scurfin itself is regulated. Nevertheless, the discovery that mutations
`in human FOXP3 lead to a syndrome very similar to scurfy (see
`Wildin et al.18 and Bennett et al.26, this issue) suggests that the
`scurfy mouse provides an invaluable model system through which
`to better understand, and ultimately to develop treatments for,
`severe autoimmune-related dysfunctions.
`
`Methods
`Animals. We conducted animal studies following PHS guidelines. Double-
`mutant sf Otcspf mice were maintained as described10. Carriers of the Otcspf
`mutation were identified by amplification of genomic DNA with the
`primers 5´–TCTGCTGGGAGGACACCC–3´ and 5´–GGCATTATCTAAG
`GAGAAGCATCA–3´, and subsequent digestion with the restriction
`endonuclease MseI (ref. 27). The original breeding stocks were obtained
`from Oak Ridge National Laboratory (ORNL), and Mus musculus casta-
`neous animals (CAST/Ei) were obtained from The Jackson Laboratory.
`
`Subcloning and sequencing the candidate region. We sequenced four BAC
`clones (CITB genomic library, Research Genetics) encompassing the sf crit-
`ical interval by the random shotgun method. All genomic sequences were
`subjected to BLAST (ref. 28) analysis against all publicly available GenBank
`databases, and exons were predicted using GENSCAN (ref. 29). All results
`of the sequence analyses were deposited in a viewer developed in-house (S.
`Bobick and G. Brickner, pers. comm.).
`
`Transgenic mice. We purified a 30.8-kb HpaI fragment from BAC K60 by
`treatment with GELase (Epicentre Technologies) after field-inversion gel elec-
`trophoresis (FIGE) through a 1% SeaPlaque GTG agarose (FMC BioProd-
`ucts) gel in 1×TAE. The HpaI fragment was ligated to a linearized, blunt-end-
`ed SuperCos I (Stratagene) vector overnight, then transformed into electro-
`competent DH10B. To prepare DNA for oocyte microinjection, the cosmid
`construct (20 µg) was digested with NotI and the ∼31-kb insert was isolated by
`FIGE on a 1.1% SeaPlaque GTG agarose gel in 1×TAE. The fragment was
`purified as above and dialyzed extensively against microinjection buffer (10
`mM Tris, 0.25 mM EDTA, pH 7.5). Microinjections of (C57BL/6×SJL)F2
`hybrid oocytes were carried out by DNX Transgenic Services.
`Lymph nodes from transgenic animals were removed, minced to create
`single-cell suspensions and analyzed for cell number and phenotype. Phe-
`notypic characterization was performed by staining of cells with fluores-
`cently labeled antibodies to CD4 and CD8 (Caltag) and analysis on a
`MoFlo flow cytometer (Cytomation).
`To generate the ‘scurfy’ mutant transgene, the single EcoRV fragment
`(∼11 kb) from the wild-type cosmid construct was first subcloned into
`pBluescript SK+ (Stratagene). An ∼4-kb Asp718 fragment, including exon 8
`of Foxp3, was then subcloned into pBS SK+ to generate the template for
`site-directed mutagenesis. Mutagenic primers 5´–GCAGCAAGAGCTC
`TTTTGTCCATTGAGG–3´ and 5´–CCTCAATGGACAAAAGAGCTCTT
`GCTGC–3´ were used to introduce the ‘scurfy’ 2-bp insertion, using the
`
`nature genetics • volume 27 • january 2001
`
`71
`
`Page 4 of 6
`
`YEDA EXHIBIT NO. 2071
`MYLAN PHARM. v YEDA
`IPR2015-00644
`
`

`
`© 2001 Nature Publishing Group http://genetics.nature.com
`
`MPNPRPAKPMAPSLALGPSPGVLPSWKTAPKGSELLGTRGSGGPFQGRDL
`|||||| || ||||||||||| |||: ||| |:||| || || ||||||
`MPNPRPGKPSAPSLALGPSPGASPSWRAAPKASDLLGARGPGGTFQGRDL
`
`RSGAH.TSSSLNPLPPSQLQLPTVPLVMVAPSGARLGPSPHLQALLQDRP
`| ||| .||||||:|||||||||.|||||||||||||| |||||||||||
`RGGAHASSSSLNPMPPSQLQLPTLPLVMVAPSGARLGPLPHLQALLQDRP
`
`HFMHQLSTVDAHAQTPVLQVRPLDNPAMISLPPPSAATGVFSLKARPGLP
`|||||||||||||.|||||| ||:.|||||| ||. ||||||||||||||
`HFMHQLSTVDAHARTPVLQVHPLESPAMISLTPPTTATGVFSLKARPGLP
`
`PGINVASLEWVSREPALLCTFPRSGTPRKDSNLLAAPQGSYPLLANGVCK
`|||||||||||||||||||||| ||||| | | || |||||||||||
`PGINVASLEWVSREPALLCTFPNPSAPRKDSTLSAVPQSSYPLLANGVCK
`
`WPGCEKVFEEPEEFLKHCQADHLLDEKGKAQCLLQREVVQSLEQQLELEK
`||||||||||||:|||||||||||||||:||||||||.|||||||| |||
`WPGCEKVFEEPEDFLKHCQADHLLDEKGRAQCLLQREMVQSLEQQLVLEK
`*
`EKLGAMQAHLAGKMALAKAPSVASMDKSSCCIVATSTQGSVLPAWSAPRE
`||| |||||||||||| || |||| || |||||| .|| |.|||| |||
`EKLSAMQAHLAGKMALTKASSVASSDKGSCCIVAAGSQGPVVPAWSGPRE
`
`50
`
`50
`
`99
`
`100
`
`149
`
`150
`
`199
`
`200
`
`249
`
`250
`
`299
`
`300
`
`Fig. 5 Mouse and human scurfin proteins contain
`a highly conserved forkhead domain. Needle-
`man-Wunsch algorithm was used to align the
`mouse and human sequences; the two proteins
`have an overall similarity index of 86%. The fork-
`head domain, with a similarity index of 94%, is
`shaded, the C2H2 zinc finger domain is boxed and
`potential nuclear localization signals are under-
`lined. Asterisk indicates position of 2-bp insertion
`in sf mutant. One difference between the hypo-
`thetical JM2 transcript and mouse sf cDNAs was
`an in-frame insertion of 180 bp in the forkhead
`domain of the human sequence (between coding
`exons 10 and 11). The arrow below the human
`FOXP3 sequence indicates the site of this inser-
`tion, which would encode an additional 60 aa.
`
`APDGGLFAVRRHLWGSHGNSSFPEFFHNMDYFKYHNMRPPFTYATLIRWA
`||| |||||||||||||||.|||| |||||||:||||||||||||||||
`APD.SLFAVRRHLWGSHGNSTFPEFLHNMDYFKFHNMRPPFTYATLIRWA
`
`349
`
`349
`
`ILEAPERQRTLNEIYHWFTRMFAYFRNHPATWKNAIRHNLSLHKCFVRVE
`||||||:||||||||||||||||:||||||||||||||||||||||||||
`ILEAPEKQRTLNEIYHWFTRMFAFFRNHPATWKNAIRHNLSLHKCFVRVE
`
`399
`
`399
`
`SEKGAVWTVDEFEFRKKRSQRPNKCSNPCP..
`||||||||||| ||||||||||.:|||| |
`SEKGAVWTVDELEFRKKRSQRPSRCSNPTPGP
`
`429
`
`431
`
`5´–GGCATCCACCGTTGAGAGC–3´. In addi-
`tion, the Stratagene Human Universal cDNA
`Library (HUCL) was screened by hybridization
`with a 730-bp fragment corresponding to the 5´
`half of the gene, obtained by PCR with primers
`5´–ATGCCCAACCCCAGGCCTGGC–3´
`and
`5´–CTCCAGAGACTGTACCATCTC–3´. A sin-
`gle polyadenylated clone was identified. The
`complete cDNA sequence was ascertained by
`combining various fragments obtained by all methods. To confirm that the
`intron included in the hypothetical JM2 cDNA sequence is in-frame with the
`rest of the coding sequence, we isolated a FOXP3-containing BAC from the
`CITB_978_SKB genomic library (Research Genetics) and directly sequenced
`across the appropriate region.
`
`Quickchange kit (Stratagene). The cycling conditions were 95 °C for 45 s,
`followed by 16 cycles of 95 °C for 30 s, 55 °C for 60 s, 68 °C for 14 min, and
`a final elongation step of 72 °C for 5 min. After digestion with DpnI and
`transformation into Escherichia coli strain DH10B, a plasmid containing
`the appropriate sequence alteration was identified by sequencing. The
`mutated Asp718 fragment was then re-introduced into the cosmid con-
`struct by reversing the two original subcloning steps described above.
`Preparation of DNA for oocyte microinjection was as above.
`
`Full-length mouse and human cDNAs. cDNA libraries prepared from nor-
`mal 10-d mouse thymus, adult mouse spleen (M.A. Gayle, pers. comm.) and
`mouse 15-d embryo (5´-STRETCH cDNA library, Clontech) were screened
`by nested PCR to obtain additional sequences 5´ and 3´ of the 980-bp Foxp3
`fragment described above. In these PCRs, vector-specific primers were paired
`with Foxp3-specific primers. For all three libraries, we used the following
`λgt10 vector primers: 5´–CGAGCTGCTCTATAGACTGCTGGGTAGTC–3´
`nested with 5´–CCTTTTGAGCAAGTTCAGCCTGG–3´; and 5´–TTGCAT
`ATCGCCTCCATCAACAAAC–3´ nested with 5´–GGTGGCTTATGAGTAT
`TTCTTCC–3´. Foxp3-specific primers used for isolating 5´ end sequences
`were as follows: 5´–CCAGGCCACTTGCAGA–3´ nested with 5´–CAT
`TTGCCAGCAGTGGGTAG–3´, and 5´–GCAGCTGGGATGGTGGCAG–3´
`nested with 5´–GCCCCACTTCGCAGGTCC–3´. For the 3´ end, a number of
`different primers were used, such as 5´–CATGGACTACTTCAAGTAC
`CAC–3´, and 5´–GTCAGAACACGCTCGTGTGCAC–3´, nested with
`5´–GTACACACATGCAGCCCCTCC–3´. We amplified the concentrated
`phage library stock (1 µl) with outer primers (94 °C for 3 min, followed by 35
`cycles of 94 °C for 45 s, 62 °C for 90 s, 72 °C for 90 s). This primary reaction (1
`µl) was then used as template in a second round of PCR using the appropriate
`nested primers (same cycling conditions). We also obtained 5´ sequences by
`applying the RACE technique on normal thymus and spleen RNAs, following
`the manufacturer’s instructions (Gibco-BRL 5´-RACE System v. 2.0). Full-
`length cDNA sequences of the alternative forms were ascertained by combin-
`ing all overlapping sequences; RT–PCR using primers from the extreme 5´
`and 3´ ends of Foxp3 cDNAs confirmed the structures as shown.
`We originally isolated human FOXP3 cDNA as two overlapping PCR prod-
`ucts from prostate cDNA (Marathon, Clontech). Primers were designed
`based on the sequence of JM2 and its similarity to the mouse gene:
`5´–CACACTGCCCCTAGTCATGG–3´ and 5´–GCATGGCACTCAGCTTC
`TC–3´ to amplify the 5´ region; 5´–GATGGTACAGTCTCTGGAG–3´ and
`5´–GCAAGACAGTGGAAACCTCAC–3´ for the 3´ region. To obtain addi-
`tional 5´ and 3´ sequences, including the UTRs, cDNA libraries derived from
`peripheral blood lymphocytes (λgt10 vector, M.A. Gayle, pers. comm.) and
`testis (λgt11 vector, Clontech) were screened with vector-specific/gene-spe-
`cific primer pairs. The longest 5´ extension was obtained from the testis
`λgt11
`library
`using
`vector-specific
`primer
`5´–CGGTTTCCAT
`ATGGGGATTGGTGGCGAC–3´ paired with the FOXP3 anti-sense primer
`
`Foxp3 expression. Northern-blot analysis was performed on RNA extract-
`ed from normal and transgenic tissues using reagents from Ambion (Total-
`ly RNA and NorthernMax-Gly kits) and overnight transfer to HyBond N
`filters (Amersham). A 360-bp fragment of Foxp3 amplified from thymus
`cDNA with primers 5´–CAGCTGCCTACAGTGCCCCTAG–3´ and 5´–CAT
`TTGCCAGCAGTGGGTAG–3´ was labeled with 32P-—dCTP by random
`hexamer incorporation (MegaPrime kit, Amersham) and used to probe the
`filters. After washing at high stringency, the filters were exposed to Hyper-
`film MP (Amersham Life Science).
`We also examined Foxp3 expression by real-time RT–PCR using an ABI
`Prism 7700 instrument. Random-primed first-strand cDNA (SuperScript
`Preamplification System, Gibco-BRL) was used as template in separate-tube
`amplification reactions. All samples were run in duplicate in each experiment.
`Primers were custom designed and obtained from PE Biosystems. Foxp3
`primers were 5´–GGCCCTTCTCCAGGACAGA–3´ and 5´–GCTGATCATG
`GCTGGGTTGT–3´, and the internal TaqMan probe was 5´–6FAM-AGCTTC
`ATCCTAGCGGTTTGCCTGAGAATAC-TAMRA–3´; Dad1 primers were
`5´–CCTCTCTGGCTTCATCTCTTGTGT–3´ and 5´–CCGGAGAGATGC
`CTTGGAA–3´, with TaqMan probe 5´–6FAM-AGCTTCATCCTAGCG
`GTTTGCCTGAGAATAC-TAMRA–3´. The TaqMan Universal Master Mix
`(PE Applied Biosystems) was used for all the reaction components, except
`primers, probe and template. The final primer concentrations were 300 nM
`for Foxp3 and 50 nM for Dad1. The final probe concentration for both Foxp3
`and Dad1 was 100 nM. Cycling conditions were 50 °C for 2 min; 95 °C for 10
`min; and 40 cycles of 95 °C for 15 s, 60 °C for 1 min. The data was collected
`and analyzed by the ABI Prism 7700 Sequence Detection System Software,
`

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket